Toronto, Ontario--(Newsfile Corp. - November 25, 2021) - Kovo HealthTech Corporation (TSXV: KOVO) ("Kovo", or the "Company") - a leader in healthcare Billing-as-a-Service - is pleased to announce that it has extended its contract with Hybrid Financial Ltd.
The service provided by Hybrid to the Company is a database of Registered Financial Professionals in North America. Hybrid is not promoting the specific purchase or sale of securities. It provides its database, technology, and call center services to enable the issuer to disseminate its information to Financial Professionals only. Hybrid provides its services directly to the Company.
Hybrid complies with all applicable securities laws and the policies of the TSX Venture Exchange (the "TSXV") in providing the Services.
Hybrid has been re-engaged by the Company for an initial period of one year starting on December 5, 2021 (the "Initial Term") and then shall be renewed automatically for successive three month periods thereafter, unless terminated by the Company in accordance with the Agreement. Hybrid will be paid a monthly fee of $22,500, plus applicable taxes, during the Initial Term.
About Hybrid Financial Ltd.
Hybrid Financial connects issuers to the investment community across North America. Using a data driven approach, Hybrid provides its clients with comprehensive coverage of both American and Canadian markets. Hybrid Financial has offices in Toronto and Montreal.
About Kovo HealthTech Corporation
Kovo HealthTech Corporation is a growing healthcare technology company that specializes in Billing-as-a-Service offering SaaS-style recurring revenue contracts and software for US healthcare clinics, hospitals and private practices. Kovo helps healthcare providers digitally track and manage complex patient care registration, services, billing and payments in a seamless way, using its proprietary OneRev technology platform. By offering effective billing practices and technology through long-term SaaS-style contracts, Kovo helps healthcare practitioners focus on offering quality care. To learn more about Kovo and to keep up-to-date on Kovo news, visit www.kovo.co.
For more information:
Greg Noble, CEO
investors@kovo.co
1-866-558-6777
Debra Quinn
deb@kovo.co
1-866-558-6777
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105090
